Kasuwar Viscosupplementation 2020 Ta hanyar Kuɗi, Babban Shafi & Hasashen Ci gaban Yanki

Wayar Indiya
sakin waya
Written by Editan Manajan eTN

Selbyville, Delaware, Amurka, Nuwamba 4 2020 (Wiredrelease) Haskaka Kasuwar Duniya, Inc -: Rahoton bincike na Kasuwar Viscosupplementation yana ba da sabbin bayanan masana'antu da yanayin masana'antu a nan gaba, yana ba ku damar gano samfuran da ƙarshen masu amfani da ke haifar da haɓakar Haraji da riba. Rahoton masana'antu ya jera manyan masu fafatawa kuma yana ba da haske game da dabarun masana'antu Binciken mahimman abubuwan da ke tasiri kasuwa.

Ana sa ran kasuwar kayan haɓakawa ta duniya za ta lura da babban ci gaba saboda karuwar cututtukan osteoarthritis a cikin yawan geriatric na duniya. Osteoarthritis yawanci yana shafar haɗin gwiwa a hannaye, gwiwoyi, kashin baya, da kwatangwalo, kuma yana da alhakin samar da babban farashin kiwon lafiya tsakanin majiyyatan sa. Daga cikin waɗannan, ƙwanƙwasa osteoarthritis shine nau'in ciwon sanyi da aka fi sani, wanda ke shafar miliyoyin mutane a duniya.

Nemi samfurin kwafin wannan rahoton @ https://www.gminsights.com/request-sample/detail/4212

Kamar yadda Gidauniyar Osteoarthritis ta Duniya ta yi rahoton, sama da mutane miliyan 300 ne ke fama da cutar osteoarthritis. Ana hasashen wannan babban wurin shakatawa mai girma kuma koyaushe yana yin tasiri ga ci gaban kasuwa cikin shekaru masu zuwa. Viscosupplementation hanya ce ta likitanci mara ƙarancin ƙarfi wacce baya buƙatar majiyyata don yin aikin maye gurbin gwiwa, wanda ke haifar da ƙarin buƙatu don tsarin da haɓaka hangen nesa na masana'antu.

Yayin da yake zama ɗan ƙanƙara, magani na viscosupplementation yana ba da fa'idodi da yawa kamar sauƙaƙa wa marasa lafiya tafiya, zama da kwanciyar hankali, rage kumburi da rashin jin daɗi a cikin gidajen da abin ya shafa, da ingantaccen inganta rayuwar yau da kullun na marasa lafiya, wanda shine dalilin da yasa yawancin cututtukan arthritis. marasa lafiya suna zaɓar hanya, suna ƙara yawan aiwatar da shi.

Dangane da rahoton bincike na GMI Inc, kasuwar ingantattun kayan kwalliya ta duniya na iya zarce kimar dala biliyan 5.3 nan da 2026.

Dangane da samfurin, gabaɗayan kasuwar ƙwaƙƙwaran ƙwaƙƙwaran an rarraba su zuwa allura 5, allura 3, da allura guda ɗaya. Daga cikin waɗannan, ɓangaren alluran guda 3 ana hasashen zai yi rikodin girma mai girma a cikin shekaru masu zuwa saboda karuwar karɓuwa da kuma samun samfuran tallace-tallace da yawa don maganin osteoarthritis. A zahiri, ɓangaren ya sami ƙimar sama da dala biliyan 1.3 a cikin 2019.

Ana gudanar da maganin injections na 3 ta hanyar tsaka-tsakin mako-mako kuma zai iya rage yawan zafin da mai haƙuri ya fuskanta a cikin makonni. Sakamakon abubuwan da aka ambata a baya, karuwar buƙatar alluran 3 na iya haifar da rabon kashi, ta haka zai haɓaka girman kasuwa gaba ɗaya.

Game da amfani da ƙarshen, sashin asibitoci yana wakiltar kaso na masana'antu na sama da 59% a cikin 2019. Babban rabon kashi ana danganta shi da hauhawar adadin asibitoci a duk faɗin duniya. Bugu da kari, karuwar samun ingantattun jiyya na viscosupplementation ga marasa lafiya na osteoarthritis a asibitoci zai kara fitar da girman sashi.

A zahiri, bisa ga labarin da aka buga kwanan nan, a cikin 2019, Jamus tana da kusan asibitoci 2000. Tare da haɓaka mai da hankali kan haɓaka kayan aikin kiwon lafiya, asibitoci za su ba da ingantaccen jiyya ga marasa lafiya na osteoarthritis, ta yadda za su samar da manyan kudaden shiga.

A kan yankin yanki, an kiyasta kasuwar ingantacciyar hanyar Spain za ta iya hasashen haɓakar haɓakar kudaden shiga saboda dalilai kamar haɓaka yawan geriatric da haɓaka adadin cututtukan osteoarthritis a cikin wannan alƙaluma. A gaskiya ma, kamar yadda bayanan da aka buga kwanan nan, fiye da mutane miliyan 7 suna fama da ciwon osteoarthritis a kasar tare da mutane da yawa suna buƙatar jiyya na viscosupmentation don rage yawan ciwo a cikin gidajensu.

Neman keɓancewa @ https://www.gminsights.com/roc/4212

Manyan 'yan kasuwa kuma suna ƙara ɗaukar dabarun haɓaka kasuwanci kamar saye, haɗin gwiwa, da ƙaddamar da sabbin samfura suna kawo ƙarin kudaden shiga. Ɗaukar watan Yuni na 2019 alal misali, Anika Therapeutics ya nuna Hyalofast, sabuwar sinadarin sa na tushen hyaluronic acid wanda zai iya taimakawa tare da gyaran guringuntsi a cikin marasa lafiya.

Yanayin gasa na kasuwar kayan haɓakawa ta duniya ya haɗa da 'yan wasa kamar Genzyme Corporation, Wellchem ​​Pharmaceuticals, Zimmer Biomet, Mylan Inc., Johnson & Johnson Services, Chugai Pharmaceutical Co., Bioventus, Aptissen, da Anika Therapeutics da sauransu. 

Babin Sashi na Teburin entunshi 

Babi na 4. Kasuwar Viscosupplementation, Ta Samfur

4.1. Yanayin maɓallin keɓaɓɓu

4.2. Allura guda daya

4.2.1. Girman kasuwa, ta yanki, 2015 - 2026 (Dala Miliyan)

4.3. 3 allurai

4.3.1. Girman kasuwa, ta yanki, 2015 - 2026 (Dala Miliyan)

4.4. 5 allurai

4.4.1. Girman kasuwa, ta yanki, 2015 - 2026 (Dala Miliyan)

Babi na 5. Kasuwar Viscosupplementation, Ta Tushen Asalin

5.1. Yanayin maɓallin keɓaɓɓu

5.2. Asalin Avian

5.2.1. Girman kasuwa, ta yanki, 2015 - 2026 (Dala Miliyan)

5.3. Asalin Ba-Afiya

5.3.1. Girman kasuwa, ta yanki, 2015 - 2026 (Dala Miliyan) 

Binciko cikakken abin da ke ciki (TOC) na wannan rahoton @ https://www.gminsights.com/toc/detail/viscosupplementation-market

An wallafa wannan abun ta kamfanin Global Market Insights, kamfanin Inc. Ma'aikatar Labaran WiredRelease ba ta shiga cikin ƙirƙirar wannan ƙunshiyar ba. Don binciken sabis na sakin latsawa, da fatan za a same mu a [email kariya].

<

Game da marubucin

Editan Manajan eTN

eTN Manajan edita na aiki.

Share zuwa...